ISSN 1399-0004
Tarique et al., 2016), anti-inflammatory (Oliviero et al., 2018), anticarcinogenic (Niedzwiecki et al., 2016), antiallergic (Jurkov et al., 2015), antibiotic (Xie et al., 2017), and immunomodulatory (Nour et al., 2018) properties
People with treatment-resistant depression Those with PTSD or anxiety linked to inflammation Individuals with fibromyalgia, chronic pain, or autoimmune disorders (which often overlap with mental health conditions) Limitations & Considerations LDN is not FDA-approved for depression or anxiety , so its use is off-label
Muscle tears and strains Hamstring tears Calf strains Shoulder muscle injuries Promotes faster muscle fiber repair and reduces scar tissue formation
10.1016/j.neuint.2020.104815 166 ZhangX